Pharming Group NV (PHAR)
11.96
+0.50
(+4.36%)
USD |
NASDAQ |
Aug 25, 16:00
11.96
0.00 (0.00%)
After-Hours: 17:27
Pharming Group Market Cap : 846.51M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 811.12M |
| August 21, 2026 | 838.72M |
| August 20, 2026 | 826.69M |
| August 19, 2026 | 838.72M |
| August 18, 2026 | 842.97M |
| August 17, 2026 | 834.47M |
| August 14, 2026 | 829.52M |
| August 13, 2026 | 874.11M |
| August 12, 2026 | 837.30M |
| August 11, 2026 | 865.62M |
| August 10, 2026 | 803.33M |
| August 07, 2026 | 775.02M |
| August 06, 2026 | 767.94M |
| August 05, 2026 | 755.56M |
| August 04, 2026 | 726.18M |
| August 03, 2026 | 695.04M |
| July 31, 2026 | 713.44M |
| July 30, 2026 | 760.86M |
| July 29, 2026 | 850.04M |
| July 28, 2026 | 910.21M |
| July 27, 2026 | 912.74M |
| July 24, 2026 | 884.82M |
| July 23, 2026 | 923.75M |
| July 22, 2026 | 909.02M |
| July 21, 2026 | 920.59M |
| Date | Value |
|---|---|
| July 20, 2026 | 919.54M |
| July 17, 2026 | 944.79M |
| July 16, 2026 | 932.17M |
| July 15, 2026 | 939.88M |
| July 14, 2026 | 940.93M |
| July 13, 2026 | 965.83M |
| July 10, 2026 | 972.15M |
| July 09, 2026 | 984.77M |
| July 08, 2026 | 1.003B |
| July 07, 2026 | 1.014B |
| July 06, 2026 | 1.004B |
| July 02, 2026 | 965.83M |
| July 01, 2026 | 957.83M |
| June 30, 2026 | 974.25M |
| June 29, 2026 | 939.88M |
| June 26, 2026 | 935.67M |
| June 25, 2026 | 930.76M |
| June 24, 2026 | 910.42M |
| June 23, 2026 | 902.71M |
| June 22, 2026 | 891.48M |
| June 18, 2026 | 902.97M |
| June 17, 2026 | 887.28M |
| June 16, 2026 | 877.46M |
| June 15, 2026 | 898.85M |
| June 12, 2026 | 898.15M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ProQR Therapeutics NV | 333.75M |
| NewAmsterdam Pharma Co. NV | 3.214B |
| argenx SE | 63.09B |
| DBV Technologies SA | 881.83M |
| ACADIA Pharmaceuticals, Inc. | 5.264B |
Market Cap Related Metrics
| PE Ratio | 96.22 |
| PS Ratio | 2.404 |
| Price to Book Value | 3.293 |
| Price to Free Cash Flow | 34.26 |
| Price | 11.96 |
| Earnings Yield | 1.04% |
| Operating PE Ratio | 39.39 |
| Normalized PE Ratio | 53.68 |